Lep gene and leptin concentration in serum of schizophrenia patients with metabolic syndrome
Introduction Schizophrenia is associated with lower life expectancy due to cardiovascular disease. Metabolic syndrome (MetS) occupies an important place among the main problems. Indicators of hormones regulating metabolism may be appealing candidates as biomarkers of metabolic side-effects. Certai...
Main Authors: | A. Boiko, I. Pozhidaev, D. Paderina, E. Kornetova, S. Ivanova |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821004387/type/journal_article |
Similar Items
-
Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
by: D. Paderina, et al.
Published: (2021-04-01) -
Investigation of the role of polymorphic variants FTO gene in schizophrenia patients with metabolic syndrome
by: I. Pozhidaev, et al.
Published: (2021-04-01) -
Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
by: Irina A. Mednova, et al.
Published: (2020-10-01) -
The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia
by: Diana Z. Paderina, et al.
Published: (2022-07-01) -
Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
by: Anastasiia S. Boiko, et al.
Published: (2022-10-01)